Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Endoscopy|May 5, 2018
Detection of clinically relevant serrated polyps during screening colonoscopy: results from seven cooperating centers within the German colorectal screening programChristoph Schramm, Katharina Janhsen, Jan-Hinnerk Hofer, et al.
Angiogenesis|July 25, 2013
Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cellsIvanka Dimova, Ruslan Hlushchuk, Andrew Makanya, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 20, 2020
The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in miceHuikuan Chu, Lu Jiang, Bei Gao, et al.
Hepatology Communications|January 27, 2023
Malassezia restricta promotes alcohol-induced liver injurySuling Zeng, Phillipp Hartmann, Minji Park, et al.
Frontiers in Medicine|December 13, 2024
Spleen stiffness measurements during recompensation in patients with acutely decompensated liver cirrhosis: preliminary findings of a pilot studyDilan Elcin Gülcicegi, Jonathan Hannemann, Martin Bürger, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
Environmental Microbiology Reports|April 23, 2024
Isolation, characterisation and description of the roseoflavin producer Streptomyces berlinensis sp. novJimmy Jonathan Liunardo, Sebastien Messerli, Ann-Kathrin Gregotsch, et al.
Journal of Gastroenterology and Hepatology|April 9, 2020
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Münevver Demir, Sonja Lang, Anna Martin, et al.
Gut Microbes|January 2, 2026
Bile salt hydrolase activity as a rational target for MASLD therapyElizabeth V Jones, Yongtao Wang, Wenchao Wei, et al.
Nutrition Research (New York, N.Y.)|September 26, 2022
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver diseaseKathrin Heinzer, Sonja Lang, Fedja Farowski, et al.
Pageof 6